This patented technology has wide clinical applications, including:
- ADHD diagnosis and therapy, by quantifying attention and impulsivity levels.
- Rehabilitation for brain injuries, by measuring recovery of motor control and cognitive inhibition.
- Mental health treatment, by tracking impulsive responses in conditions like PTSD, anxiety, and mood disorders.
- Clinical research, by providing reliable endpoints for evaluating treatment outcomes.
“This patent is a significant step in our mission to merge cutting-edge XR technology with clinical practice,” said Miki Levy, CTO of XRHealth. “For the first time, clinicians can measure impulsivity objectively in a controlled XR environment. This means more accurate diagnoses, better monitoring of treatment progress, and new opportunities for personalized care across ADHD, brain injury rehabilitation, and mental health.”
The new patent strengthens XRHealth’s intellectual property portfolio and reinforces its position as a pioneer in evidence-based XR therapeutic healthcare solutions.
About XRHealth
XRHealth is a leading provider of AI-powered, immersive healthcare solutions, leveraging extended reality (XR) technology to transform patient care and rehabilitation. XRHealth offers an advanced therapeutic platform supporting physical therapy, cognitive rehabilitation, pain management, and mental health. With a mission to improve clinical outcomes through innovation, XRHealth integrates mixed reality, motion analytics, and AI-driven insights into diverse healthcare settings worldwide. For more information visit: www.xr.health
Media Contact
XRHealth Public Relations, XRHealth, 1 857-990-6111, [email protected], xr.health
SOURCE XRHealth
